125 related articles for article (PubMed ID: 3924051)
1. Potentiation by alpha-difluoromethylornithine of the activity of 3,4-dihydroxybenzylamine, a tyrosinase-dependent melanolytic agent, against B16 melanoma.
Prakash NJ; Sunkara PS; Sjoerdsma A
Biochem Pharmacol; 1985 Jun; 34(11):1887-90. PubMed ID: 3924051
[TBL] [Abstract][Full Text] [Related]
2. Effect of inhibition of polyamine biosynthesis by DL-alpha-difluoromethylornithine on the growth and melanogenesis of B16 melanoma in vitro and in vivo.
Sunkara PS; Chang CC; Prakash NJ; Lachmann PJ
Cancer Res; 1985 Sep; 45(9):4067-70. PubMed ID: 3928149
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.
Sunkara PS; Prakash NJ; Rosenberger AL; Hagan AC; Lachmann PJ; Mayer GD
Cancer Res; 1984 Jul; 44(7):2799-802. PubMed ID: 6426786
[TBL] [Abstract][Full Text] [Related]
4. Effects of tyrosinase activity on the cytotoxicity of 3,4-dihydroxybenzylamine and buthionine sulfoximine in human melanoma cells.
Prezioso JA; Fitzgerald GB; Wick MM
Pigment Cell Res; 1990; 3(2):49-54. PubMed ID: 2117268
[TBL] [Abstract][Full Text] [Related]
5. Effects of DL-alpha-difluoromethylornithine on the growth and metastasis of B16 melanoma in vivo.
Kubota S; Ohsawa N; Takaku F
Int J Cancer; 1987 Feb; 39(2):244-7. PubMed ID: 3100460
[TBL] [Abstract][Full Text] [Related]
6. Regulation of ornithine decarboxylase in B16 mouse melanoma cells: synergistic activation of melanogenesis by alphaMSH and ornithine decarboxylase inhibition.
Sanchez Mas J; Martijnez-Esparza M; Bastida CM; Solano F; Penafiel R; Garcija-Borron JC
Biochim Biophys Acta; 2002 Jan; 1542(1-3):57-65. PubMed ID: 11853879
[TBL] [Abstract][Full Text] [Related]
7. The effect of combination treatment with alpha-difluoromethylornithine and Corynebacterium parvum on B16 melanoma growth and tumoricidal effector cell generation in vivo.
Bowlin TL; Rosenberger AL; Sunkara PS
Cancer Immunol Immunother; 1985; 20(3):214-8. PubMed ID: 3933819
[TBL] [Abstract][Full Text] [Related]
8. Effects of inhibitors of polyamine biosynthesis on the growth and melanogenesis of murine melanoma cells.
Käpyaho K; Sinervirta R; Jänne J
Cancer Res; 1985 Apr; 45(4):1444-8. PubMed ID: 3919940
[TBL] [Abstract][Full Text] [Related]
9. Effects of treatments with alpha-difluoromethylornithine and hyperthermia on the growth and polyamine metabolism of Harding-Passey murine melanoma.
Lopez Ballester JA; Peñafiel R; Cremades A; Valcarcel MM; Solano F; Lozano JA
Anticancer Res; 1991; 11(2):691-6. PubMed ID: 1905904
[TBL] [Abstract][Full Text] [Related]
10. Effects of the irreversible ornithine decarboxylase inhibitor, alpha-difluoromethylornithine, aflatoxin B1, and choline deficiency on hepatocarcinogenesis.
Sondergaard D; Taylor F; Newberne PM
Toxicol Pathol; 1985; 13(1):36-49. PubMed ID: 2412277
[TBL] [Abstract][Full Text] [Related]
11. 3,4-Dihydroxybenzylamine: an improved dopamine analog cytotoxic for melanoma cells in part through oxidation products inhibitory to dna polymerase.
FitzGerald GB; Wick MM
J Invest Dermatol; 1983 Feb; 80(2):119-23. PubMed ID: 6401786
[TBL] [Abstract][Full Text] [Related]
12. 3,4-Dihydroxybenzylamine: a dopamine analog with enhanced antitumor activity against B16 melanoma.
Wick MM
J Natl Cancer Inst; 1979 Dec; 63(6):1465-7. PubMed ID: 292814
[TBL] [Abstract][Full Text] [Related]
13. Anchorage dependency effects on difluoromethylornithine cytotoxicity in human lung carcinoma cells.
Luk GD; Baylin SB
Cancer Res; 1986 Apr; 46(4 Pt 1):1844-8. PubMed ID: 3004707
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of melanotic expression in murine melanoma cells exposed to polyamine antimetabolites.
Käpyaho K; Jänne J
Biochem Biophys Res Commun; 1983 May; 113(1):18-23. PubMed ID: 6407478
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of 4-hydroxyanisole and tyrosinase activity in variant cell lines of B16 melanoma.
Thody AJ; Oliver I; Sherbet GV
Eur J Cancer Clin Oncol; 1988 Dec; 24(12):1879-84. PubMed ID: 2851444
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor.
Marton LJ; Levin VA; Hervatin SJ; Koch-Weser J; McCann PP; Sjoerdsma A
Cancer Res; 1981 Nov; 41(11 Pt 1):4426-31. PubMed ID: 6796258
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of alpha-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma.
Meyskens FL; Kingsley EM; Glattke T; Loescher L; Booth A
Invest New Drugs; 1986; 4(3):257-62. PubMed ID: 3102397
[TBL] [Abstract][Full Text] [Related]
18. Effect of murine alpha-, beta-, and gamma-interferons in combination with alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, on the tumor growth and metastasis of B16 melanoma and Lewis lung carcinoma in mice.
Sunkara PS; Bowlin TL; Rosenberger AL; Fleischmann WR
J Biol Response Mod; 1989 Apr; 8(2):170-9. PubMed ID: 2499664
[TBL] [Abstract][Full Text] [Related]
19. Tumor angiogenesis and polyamines: alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in ovo and the proliferation of vascular endothelial cells in vitro.
Takigawa M; Enomoto M; Nishida Y; Pan HO; Kinoshita A; Suzuki F
Cancer Res; 1990 Jul; 50(13):4131-8. PubMed ID: 1693880
[TBL] [Abstract][Full Text] [Related]
20. Consequences of ornithine decarboxylase inactivation by alpha-difluoromethylornithine and 5-fluorouracil on the growth of rabbit fibroblasts.
Wong CG; Gee E; Ryan SJ
Curr Eye Res; 1985 Aug; 4(8):843-6. PubMed ID: 3930145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
